# Lakefront Biotherapeutics NV: Form 6-K, filed Oct 13, 2026

- Company: [Lakefront Biotherapeutics NV](/companies/lkft.md) (CIK 1421876)
- Form: 6-K
- Filed: 2026-10-13
- Accepted by EDGAR: Oct 13, 2026, 16:36 ET
- Period: 2026-10-13
- Accession: 0001171843-26-006602
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1421876/000117184326006602/f6k_101326.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1421876/000117184326006602/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1421876/000117184326006602/f6k_101326.htm

Filed Oct 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-006602. Last ingested by Listed: Nov 4, 2026, 10:00 ET. No prices; not investment advice.